H1N1-associated Acute Necrotizing Encephalopathy of Childhood: Successful Treatment with the "Zipper Method" and Long-Term Outcome
- PMID: 40787275
- PMCID: PMC12330974
- DOI: 10.22037/ijcn.v19i3.42211
H1N1-associated Acute Necrotizing Encephalopathy of Childhood: Successful Treatment with the "Zipper Method" and Long-Term Outcome
Abstract
Acute necrotizing encephalopathy of childhood (ANEC) is a devastating childhood disease characterized by rapid neurologic deterioration after a viral febrile illness. Seizures, encephalopathy, and fatal acute necrotizing encephalopathy are well-defined neurologic complications of H1N1 virus infections. Symmetrical, multifocal lesions on cranial magnetic resonance imaging (MRI) are the best-known features of ANEC. Various treatment options include glucocorticoids, intravenous immunoglobulin (IVIG), and plasma exchange (PEX). Herein, we present a 45-month-old girl diagnosed with ANEC and treated with a novel immunomodulation technique, the "zipper method." It is a combined treatment method in which PEX and IVIG treatments are used together. In the first session of plasma exchange, one and a half volumes of patients' plasma were removed using 5% albumin as a replacement solution. At the end of the PEX session, 0.4 g/kg IVIG infusion was started. The second PEX session was applied with one volume 24 hours after the end of the IVIG infusion. This plasma exchange-intravenous immunoglobulin cycle was repeated five times. Furthermore, this case report presents her outcome 3-years after discharge: full recovery. This case is a unique example of ANEC treated successfully with the zipper method.
Keywords: Acute necrotizing encephalopathy of childhood; H1N1; Outcome; Treatment; Zipper method.
© 2025 The Authors. Published by Shahid Beheshti University of Medical Sciences.
Conflict of interest statement
The authors declared no potential conflicts of interest with respect to the research, authorship, and/ or publication of this article.
Similar articles
-
Interventions for necrotizing soft tissue infections in adults.Cochrane Database Syst Rev. 2018 May 31;5(5):CD011680. doi: 10.1002/14651858.CD011680.pub2. Cochrane Database Syst Rev. 2018. PMID: 29851032 Free PMC article.
-
Clinical Profile, Intensive Care Needs, and Short-Term Outcome of Acute Necrotizing Encephalopathy of Childhood: A Retrospective Study From a Tertiary Care Hospital in North India.Pediatr Neurol. 2025 Sep;170:66-71. doi: 10.1016/j.pediatrneurol.2025.06.016. Epub 2025 Jun 20. Pediatr Neurol. 2025. PMID: 40617070
-
Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews.Cochrane Database Syst Rev. 2017 Jan 13;1(1):CD010369. doi: 10.1002/14651858.CD010369.pub2. Cochrane Database Syst Rev. 2017. PMID: 28084646 Free PMC article.
-
Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome.Cochrane Database Syst Rev. 2022 Mar 11;3(3):CD013130. doi: 10.1002/14651858.CD013130.pub2. Cochrane Database Syst Rev. 2022. PMID: 35274741 Free PMC article.
-
Intravenous immunoglobulin for Guillain-Barré syndrome.Cochrane Database Syst Rev. 2014 Sep 19;2014(9):CD002063. doi: 10.1002/14651858.CD002063.pub6. Cochrane Database Syst Rev. 2014. PMID: 25238327 Free PMC article.
References
-
- Mizuguchi M. Acute necrotizing encephalopathy of childhood: a novel form of acute encephalopathy prevalent in Japan and Taiwan. Brain and Development. 1997;19(2):81–92. - PubMed
-
- Kubo T, Sato K, Kobayashi D, Motegi A, Kobayashi O, Takeshita S, et al. A case of HHV-6 associated acute necrotizing encephalopathy with increase of CD56bright NKcells. Scandinavian journal of infectious diseases. 2006;38(11-12):1122–5. - PubMed
-
- Manara R, Franzoi M, Cogo P, Battistella PA. Acute necrotizing encephalopathy: combined therapy and favorable outcome in a new case. Child's Nervous System. 2006;22:1231–6. - PubMed
-
- Okumura A, Mizuguchi M, Kidokoro H, Tanaka M, Abe S, Hosoya M, et al. Outcome of acute necrotizing encephalopathy in relation to treatment with corticosteroids and gammaglobulin. Brain and Development. 2009;31(3):221–7. - PubMed